Xencor, Inc. (XNCR)
28.44
-0.86
(-2.92%)
USD |
NASDAQ |
Aug 26, 16:00
28.01
-0.44
(-1.53%)
After-Hours: 20:00
Xencor Enterprise Value : 1.891B for Aug. 25, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 25, 2026 | 1.891B |
| August 24, 2026 | 1.869B |
| August 21, 2026 | 1.780B |
| August 20, 2026 | 1.721B |
| August 19, 2026 | 1.759B |
| August 18, 2026 | 1.602B |
| August 17, 2026 | 1.432B |
| August 14, 2026 | 1.448B |
| August 13, 2026 | 1.422B |
| August 12, 2026 | 1.437B |
| August 11, 2026 | 1.356B |
| August 10, 2026 | 1.318B |
| August 07, 2026 | 1.260B |
| August 06, 2026 | 1.200B |
| August 05, 2026 | 1.188B |
| August 04, 2026 | 1.194B |
| August 03, 2026 | 1.156B |
| July 31, 2026 | 1.216B |
| July 30, 2026 | 1.311B |
| July 29, 2026 | 1.165B |
| July 28, 2026 | 1.198B |
| July 27, 2026 | 1.190B |
| July 24, 2026 | 1.159B |
| July 23, 2026 | 1.165B |
| July 22, 2026 | 1.164B |
| Date | Value |
|---|---|
| July 21, 2026 | 1.234B |
| July 20, 2026 | 1.112B |
| July 17, 2026 | 1.012B |
| July 16, 2026 | 824.87M |
| July 15, 2026 | 827.10M |
| July 14, 2026 | 824.87M |
| July 13, 2026 | 825.62M |
| July 10, 2026 | 891.77M |
| July 09, 2026 | 911.47M |
| July 08, 2026 | 937.11M |
| July 07, 2026 | 878.39M |
| July 06, 2026 | 820.41M |
| July 02, 2026 | 828.59M |
| July 01, 2026 | 856.84M |
| June 30, 2026 | 910.35M |
| June 29, 2026 | 885.61M |
| June 26, 2026 | 844.88M |
| June 25, 2026 | 821.92M |
| June 24, 2026 | 800.44M |
| June 23, 2026 | 773.04M |
| June 22, 2026 | 767.85M |
| June 18, 2026 | 666.38M |
| June 17, 2026 | 676.75M |
| June 16, 2026 | 633.79M |
| June 15, 2026 | 634.54M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Incyte Corp. | 21.57B |
| Regeneron Pharmaceuticals, Inc. | 80.89B |
| MacroGenics, Inc. | 290.34M |
| ACADIA Pharmaceuticals, Inc. | 4.379B |
| Alnylam Pharmaceuticals, Inc. | 31.79B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -21.73M |
| Revenue (Quarterly) | 51.22M |
| Total Expenses (Quarterly) | 72.95M |
| EPS Diluted (Quarterly) | -0.2864 |
| Gross Profit Margin (Quarterly) | 95.24% |
| Profit Margin (Quarterly) | -42.42% |
| Earnings Yield | -7.63% |
| Normalized Earnings Yield | -9.257 |